Clinical Trials Browser

Phase 2 × Breast Neoplasms, Male × Gefitinib × Clear all

NCT00024154 2013-01-24

Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male